Sun Pharma launches only approved sprinkle formulation cap
Sun Pharma launches only approved sprinkle formulation cap

Sun Pharma launches only approved sprinkle formulation cap

DSIJ Intelligence Article rating: 3.0

Sun Pharma launched Ezallor Sprinkle (rosuvastatin) capsules in the US market to treat three kinds of elevated lipid disorders for people who have difficulty in swallowing. It is the first and only FDA-approved sprinkle formulation of rosuvastatin capsules.

Infy single handedly pushes Sensex up by 100 points
Infy single handedly pushes Sensex up by 100 points

Infy single handedly pushes Sensex up by 100 points

DSIJ Intelligence Article rating: 5.0

The stock of Infosys was buzzing in Monday's morning session after reporting a good set of numbers for the June quarter. The company's Q1FY20 results indicated positive revenue guidance.


Index trend and stocks in action July 15, 2019
Index trend and stocks in action July 15, 2019

Index trend and stocks in action July 15, 2019

DSIJ Intelligence-3 Article rating: 5.0

The zone of 11,600-11,650 is acting as a strong hurdle for the index as per the concept of change in polarity. Going ahead, only a sustainable move above this area could trigger a possibility of the upmove. Till then, Nifty is expected to oscillate in the 11,426-11,650 range for a few more days before taking a direction. Stocks in news: Tata Steel, Indusind Bank, BHEL, FEL, Allahabad Bank, Adani Ports.

Market Close: Weekly Wrap-Up
Market Close: Weekly Wrap-Up

Market Close: Weekly Wrap-Up

DSIJ Intelligence Article rating: 5.0

Merely three indices closed in the green this week, namely: Healthcare, Pharma and Media, while all the others concluded the week on a crimson note.

PGCIL rises for the third consecutive session
PGCIL rises for the third consecutive session

PGCIL rises for the third consecutive session

DSIJ Intelligence Article rating: 3.1

The shares of Power Grid Corporation of India Ltd. (PGCIL) were up 1.1 per cent in Friday’s trading session at Rs. 207.55. This marks a gain for the third consecutive session.

RSS
First32533254325532563258326032613262Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR